Gordon Lavigne, MEd

home / authors / gordon-lavigne-med

Mr Lavigne is the chief executive officer of the Schizophrenia & Psychosis Action Alliance.

Articles

Advocacy Group Applaud Joint FDA Committee Proposed Changes to Clozapine REMS Requirements

Advocacy Group Applaud Joint FDA Committee Proposed Changes to Clozapine REMS Requirements

Heidi Anne Duerr, MPH;Gordon Lavigne, MEd

November 26th 2024

Gordon Lavigne, MEd, CEO of the Schizophrenia & Psychosis Action Alliance, talk about the joint FDA committee's vote on clozapine REMS.

Latest Updated Articles

Mini Quiz: Treatment for Pedophilia?

Published: March 19th 2021 | Updated: May 21st 2025

Mini Quiz: Treatment for Pedophilia?

Mini Quiz: Integrative Child Psychiatry

Published: April 5th 2017 | Updated: May 21st 2025

Mini Quiz: Integrative Child Psychiatry

resilience

Published: May 19th 2025 | Updated: May 21st 2025

Teaching Resilience at the 2025 APA Annual Meeting

emergency

Published: May 18th 2025 | Updated: May 21st 2025

Serious Mental Illness, Substance Use Disorders, and Long-Acting Injectables in the Emergency Setting

Mini Quiz: DSM-5 Basics

Published: August 3rd 2015 | Updated: May 21st 2025

Mini Quiz: DSM-5 Basics

Mena Mirhom, MD, FAPA, and Daanish Khorasani, MD

Published: May 16th 2025 | Updated: May 21st 2025

Why You Should Do a Media Literacy Elective in Psychiatry Residency

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.